ClinicalTrials.Veeva

Menu

GE CVUS Device Evaluation

General Electric (GE) logo

General Electric (GE)

Status

Completed

Conditions

Echocardiography

Treatments

Device: Investigational ultrasound exam

Study type

Interventional

Funder types

Industry

Identifiers

NCT05340244
217021760

Details and patient eligibility

About

The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device.

Full description

The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device. The primary objective of this study is to collect user feedback and de-identified images from the Vivid E95 ultrasound system and probes in TTE and TEE exams in a clinical setting. User feedback will include workflow, performance, user preference, image quality, device features, and open-ended feedback. The safety objective of this study is to collect safety information, including type and number of adverse events and device issues.

This is a pre-market, open label, prospective, non-randomized clinical research study conducted at one site in the United States. This study is not intended to support a comparative claim or test any hypotheses, such as superiority or non-inferiority. No clinical efficacy endpoints will be assessed.

Enrollment

8 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has a clinical indication for a TEE and/or TTE procedure with an ultrasound device
  • Has a weight of at least 5kg
  • Are able and willing to comply with study procedures
  • If less than 7 years old, has a parent or legally authorized representative able and willing to provide written consent to participate
  • If 7-17 years old, are able and willing to provide written assent to participate AND have a parent or legally authorized representative able and willing to provide written consent to participate
  • If 18 years old or older, are able and willing to provide written consent to participate

Exclusion criteria

  • Pregnant or suspected to be pregnant based on the opinion of a clinician investigator
  • Expected to be at increased risk due to study participation (e.g. due to sensitivities, relative or absolute contraindication to TEE), in the opinion of a clinician investigator
  • Previously participated in this study or are enrolled in another research study that could be expected to interfere with participation in study procedures
  • History of esophageal surgery or known vascular ring

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

Arm 1: Experimental
Experimental group
Treatment:
Device: Investigational ultrasound exam

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems